Trial Profile
A Phase IIb Clinical Study of PTS (Para-Toluenesulfonamide Injection), A Novel Local Invasive Anticancer Drug, Administered Locally and Intratumorally to Patients With Advanced Lung Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs P-toluenesulfonamide (Primary)
- Indications Lung cancer; Malignant pleural effusion
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2013 New trial record